← Browse by Condition
Medical Condition
small cell lung cancer sclc
Total Trials
2
Recruiting Now
2
Trial Phases
Phase 1, Phase 1, Phase 2
NCT06736418 Phase 1
Recruiting
Study of 225Ac-ABD147 to Establish Optimal Dose in Patients With SCLC and LCNEC of the Lung That Previously Received Platinum-based Chemotherapy
Enrollment
65 pts
Location
United States
Sponsor
Abdera Therapeutics Inc.
NCT04585750 Phase 1, Phase 2
Recruiting
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Enrollment
300 pts
Location
United States, Austr...
Sponsor
PMV Pharmaceuticals, Inc